[HTML][HTML] P‐and E‐selectin in venous thrombosis and non‐venous pathologies
M Purdy, A Obi, D Myers, T Wakefield - Journal of Thrombosis and …, 2022 - Elsevier
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
[HTML][HTML] Editor's choice–European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower …
MG De Maeseneer, SK Kakkos, T Aherne… - European Journal of …, 2022 - ejves.com
The European Society for Vascular Surgery (ESVS) has prepared new guidelines for the
treatment of patients with CVD, to update the existing ESVS guidelines on the management …
treatment of patients with CVD, to update the existing ESVS guidelines on the management …
A systematic review and meta-analysis of 12-month patency after intervention for iliofemoral obstruction using dedicated or non-dedicated venous stents
GM Majeed, K Lodhia, J Carter… - Journal of …, 2022 - journals.sagepub.com
Background: Endovascular stenting of the deep venous system has been proposed as a
method to treat patients with symptomatic iliofemoral outflow obstruction. The purpose of this …
method to treat patients with symptomatic iliofemoral outflow obstruction. The purpose of this …
Antithrombotic Therapy After Venous Interventions: AJR Expert Panel Narrative Review
S Kishore, MS Khaja, B Thornburg… - American Journal of …, 2022 - Am Roentgen Ray Soc
Interventions for thrombotic and nonthrombotic venous disorders have increased with
technical advances and more trained venous specialists. Antithrombotic therapy is essential …
technical advances and more trained venous specialists. Antithrombotic therapy is essential …
A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents
AS Badesha, PRS Bains, BRS Bains, T Khan - Journal of Vascular Surgery …, 2022 - Elsevier
Objective This review aims to summarise the efficacy and safety of dedicated venous
stenting for the treatment of obstructive chronic deep venous disease. The approaches to …
stenting for the treatment of obstructive chronic deep venous disease. The approaches to …
[HTML][HTML] Editor's Choice–Quality of life after stenting for iliofemoral venous obstruction: a randomised controlled trial with one year follow up
S Shekarchian, J Van Laanen, ME Barbati… - European Journal of …, 2023 - Elsevier
Objective Deep venous obstruction (DVO) is a great burden on the healthcare system and
patients' quality of life (QoL). Case series show stenting is safe and effective, however most …
patients' quality of life (QoL). Case series show stenting is safe and effective, however most …
A clinical guide to deep venous stenting for chronic iliofemoral venous obstruction
Background An increase in endovenous interventions for deep venous pathologies has
been observed. This article aims to provide an overview of the role of venous stenting in the …
been observed. This article aims to provide an overview of the role of venous stenting in the …
[HTML][HTML] A systematic review of the safety and efficacy of inferior vena cava stenting
RI Morris, N Jackson, A Smith, SA Black - European Journal of Vascular …, 2023 - Elsevier
Objective Inferior vena cava (IVC) stenting may provide benefit to patients with symptomatic
obstruction; however, there are no devices currently licensed for use in the IVC and …
obstruction; however, there are no devices currently licensed for use in the IVC and …
Long-term outcome of dedicated venous stents in management of chronic iliofemoral obstruction
ARM Salem, HAA AboElNeel, ME Fakhr - Journal of Vascular Surgery …, 2022 - Elsevier
Objective To study the long-term outcomes in patients with occlusive Iliofemoral chronic
venous insufficiency (CVI) of benign etiology treated by dedicated venous stents (Zilver …
venous insufficiency (CVI) of benign etiology treated by dedicated venous stents (Zilver …
Immediate postprocedure anticoagulation with factor Xa inhibitors of venous stents for nonthrombotic venous lesions does not increase stent patency
PJ Pappas, G Lakhanpal, S Lakhanpal… - Journal of Vascular …, 2022 - Elsevier
Background Many clinicians will prescribe anticoagulation therapy for patients after iliac vein
stenting to prevent early or late stent thrombosis. At present, it is unknown whether …
stenting to prevent early or late stent thrombosis. At present, it is unknown whether …